Eleven Biotherapeutics Inc. (EBIO) Trading Up 7.1%
Eleven Biotherapeutics Inc. (NASDAQ:EBIO)’s share price was up 7.1% during trading on Wednesday . The company traded as high as $4.09 and last traded at $3.93, with a volume of 1,683,893 shares traded. The stock had previously closed at $3.67.
The company’s market cap is $61.42 million. The company has a 50-day moving average price of $2.57 and a 200 day moving average price of $1.17.
In other Eleven Biotherapeutics news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the business’s stock in a transaction that occurred on Monday, June 13th. The stock was sold at an average price of $2.74, for a total transaction of $2,855,080.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.